Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 917 | 987 | 803 | 583 | 1944 | - |
Fund Return | -8.25% | -1.25% | -19.69% | -16.47% | 14.22% | - |
Place in category | 47 | 58 | 109 | 28 | 1 | - |
% in Category | 19 | 22 | 43 | 21 | 1 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS Innovation Power Eq | 5.63B | 7.47 | 6.47 | - | ||
ICBC Credit Literary Ids Eq | 5.51B | 5.38 | -10.61 | - | ||
ICBCCS China Core Value Mixed H | 3.77B | 0.00 | 0.00 | - | ||
ICBCCS China Core Value Mixed A | 3.77B | 7.48 | -11.19 | 8.39 | ||
ICBCCS MedicalHlth Care Sect Secs I | 3.74B | -10.87 | -16.59 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CMF CNI Bio Health Index | 10.36B | -22.51 | -30.05 | - | ||
GF YiLiao BaoJian Eq A | 6.97B | -8.17 | -24.93 | - | ||
Hwabao WP CSI Medical Index | 5.97B | -16.18 | -27.42 | - | ||
Penghua Medical Tech Eq | 3.78B | -12.06 | -10.59 | - | ||
ICBCCS MedicalHlth Care Sect Secs I | 3.74B | -10.87 | -16.59 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.11 | 41.97 | -1.32% | |
WuXi AppTec | CNE1000031K4 | 8.63 | 42.28 | -3.84% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 5.93 | 29.98 | -0.99% | |
Huadong Med A | CNE0000011S1 | 5.43 | 30.40 | -1.27% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 4.81 | 292.09 | -1.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review